Archive: 20/09/2019
Both natural variation in ACE concentrations and lowering BP with ACE inhibitors associated with lower risk of T2D
New research presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain (16-20 September) shows that usage of angiotensin-converting enzyme (ACE) inhibitors to ...
Sep 20, 2019